Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III)
Completed · Not applicable
Conditions studied: Advanced Cancer
In brief
ENABLE III is a randomized clinical trial that evaluates a phone-based palliative care intervention designed to improve quality of life, mood, and symptom management for patients with an advanced stage cancer and their caregivers. The primary aims of this clinical trial are to determine whether a palliative care intervention (introduced immediately or 12 weeks after diagnosis) can improve survival, quality of life, mood, symptom intensity and end-of-life care.
Key facts
- Study ID
- NCT01245621
- Run by
- Dartmouth-Hitchcock Medical Center
- People needed
- 360
- Starts
- 2010-10-01
- Expected to finish
- 2013-09-01
- Last updated by the study team
- 2014-01-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Dartmouth-Hitchcock Medical Center - Lebanon — Lebanon, New Hampshire, United States
- Dartmouth-Hitchcock Clinic - Manchester — Manchester, New Hampshire, United States
- St. Joseph Hospital — Nashua, New Hampshire, United States
- Dartmouth-Hitchcock NCCC Nashua — Nashua, New Hampshire, United States
- Providence VA Medical Center — Providence, Rhode Island, United States
- Mountainview Medical — Berlin Corners, Vermont, United States
- Veteran's Administration Hospital — White River Junction, Vermont, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.